Immunophotonics is an early stage biotechnology company engaged in the development of a proprietary novel drug product for use in an in situ autologous cancer vaccine (inCVAX) for the treatment of metastatic solid tumor cancers.

from http://www.immunophotonics.com/

Publications show all

ImmunoPhotonics has published 5 articles.

Patents show all

12Applications6Issued

SEC Filings show all

D3

Contact Information